PRTN3 and endometrial cancer: Our research group previously determined IC50 dose of ACPA as 9.3 × 10−6 M on CB1R expressing Ishikawa endometrial cancer cells at 46 hours in vitro which induced 8.9% early and 62.8% late apoptosis by FCM33.